Science Explorer Back to mapMap
Discussion
Company · Birmingham · United States

Agenta Biotechnologies (United States)

ROR OpenAlex
Research works
4
◆ 0% vs 2018-21
Citations
127
34.0 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
81%
world 40%
International
61%
world 18%
Agenta Biotechnologies (United States)

Not ranked overall: Agenta Biotechnologies (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Agenta Biotechnologies (United States) work in?

In all years, 37% of research at Agenta Biotechnologies (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Medicine (32%), Biochemistry, Genetics and Molecular Biology (26%), Materials Science (26%).

Life Sciences: 1 fractional works · 36.8% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 26.3% of its workImmunology and Microbiology: 0 fractional works · 10.5% of its workHealth Sciences: 1 fractional works · 36.8% of its workMedicine: 1 fractional works · 31.6% of its workDentistry: 0 fractional works · 5.3% of its workPhysical Sciences: 1 fractional works · 26.3% of its workMaterials Science: 1 fractional works · 26.3% of its workALL ITS WORKAgentaBiotechnologies…4fractional works, all years
Life Sciences37%Physical Sciences26%Health Sciences37%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology126.3%
    2. Immunology and Microbiology010.5%
    1. Medicine131.6%
    2. Dentistry05.3%
    1. Materials Science126.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Agenta Biotechnologies (United States)?

The most cited paper from Agenta Biotechnologies (United States) is "Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis" (Ling Li, Raynald Michel, Joshua Cohen et al., 2008), with 114 citations. Next come "Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing" (79) and "Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer" (52).

Most cited papers
#PaperReleasedCitations
1 Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis Ling Li, Raynald Michel, Joshua Cohen et al. · BMC Microbiology Open access 6 Feb 2008 114
2 Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing Megan Susan Lord, April L. Ellis, Brooke L. Farrugia et al. · Journal of Controlled Release Open access 9 Feb 2017 79
3 Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim et al. · Scientific Reports Open access 28 Aug 2019 52
4 Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis Arthur A. DeCarlo, Maria E. Belousova, April L. Ellis et al. · BMC Biotechnology Open access 11 Sep 2012 36
5 Feasibility of an HA2 Domain-Based Periodontitis Vaccine Arthur A. DeCarlo, Yi‐Fang Huang, Charles A. Collyer et al. · Infection and Immunity Open access 20 Dec 2002 31
All 10 most cited papers, with filters and sorting

Which research topics does Agenta Biotechnologies (United States) publish most on?

By volume in 2022-now: Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines and vaccines and immunoinformatics approaches.

Pneumonia and Respirator…0Pneumonia and Respiratory Infections: 0 fractional worksBacterial Infections and…0Bacterial Infections and Vaccines: 0 fractional worksvaccines and immunoinfor…0vaccines and immunoinformatics approaches: 0 fractional works
EpidemiologyMicrobiologyMolecular Biology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pneumonia and Respiratory Infections Epidemiology 0 works
  2. 2 Bacterial Infections and Vaccines Microbiology 0 works
  3. 3 vaccines and immunoinformatics approaches Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available81.2%not open18.8%

World: 40% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 18% is written across borders.

How has Agenta Biotechnologies (United States)'s research output changed?

Output in 2022-2025 was 0% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Birmingham

All research institutions in Birmingham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Agenta Biotechnologies (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.